A. Esposito

发表

Different Effects of Antihypertensive Therapies Based on Losartan or Atenolol on Ultrasound and Biochemical Markers of Myocardial Fibrosis: Results of a Randomized Trial

F. Magrini, A. Zanchetti, B. Dahlöf, 2004, Circulation.

Studies on left ventricular hypertrophy regression in arterial hypertension: a clear message for the clinician?

G. Mancia, A. Zanchetti, C. Cuspidi, 2008, American journal of hypertension.

Prevalence and correlates of multiple organ damage in a never-treated hypertensive population: role of ambulatory blood pressure

G. Mancia, A. Zanchetti, C. Cuspidi, 2008, Blood pressure monitoring.

Ambulatory heart rate and target organ damage in never-treated essential hypertensives

G. Mancia, A. Zanchetti, C. Cuspidi, 2008, Journal of Human Hypertension.

Prevalence and clinical correlates of right ventricular hypertrophy in essential hypertension

G. Mancia, A. Zanchetti, C. Cuspidi, 2009, Journal of hypertension.

The translocation of marrow MNCs after experimental myocardial cryoinjury is proportional to the infarcted area

F. Magrini, P. Rebulla, R. Pacchiana, 2004, Transfusion.

Homing of peripherally injected bone marrow cells in rat after experimental myocardial injury.

F. Magrini, A. Giorgetti, P. Rebulla, 2003, Haematologica.

Left ventricular remodeling after experimental myocardial cryoinjury in rats.

F. Magrini, U. Gianelli, M. Ciulla, 2004, The Journal of surgical research.

Ambulatory blood pressure, target organ damage and aortic root size in never-treated essential hypertensive patients

G. Mancia, A. Zanchetti, C. Cuspidi, 2007, Journal of Human Hypertension.

Retinal microvascular changes and target organ damage in untreated essential hypertensives

F. Magrini, A. Zanchetti, C. Cuspidi, 2004, Journal of hypertension.

High prevalence of retinal vascular changes in never‐treated essential hypertensives: an inter‐ and intra‐observer reproducibility study with non‐mydriatic retinography

F. Magrini, A. Zanchetti, D. Salerno, 2004, Blood pressure.

Lack of association between serum uric acid and organ damage in a never-treated essential hypertensive population at low prevalence of hyperuricemia.

G. Mancia, A. Zanchetti, C. Cuspidi, 2007, American journal of hypertension.

Metabolic syndrome and biventricular hypertrophy in essential hypertension

G. Mancia, A. Zanchetti, C. Cuspidi, 2009, Journal of Human Hypertension.

Effects of antihypertensive treatment on ultrasound measures of myocardial fibrosis in hypertensive patients with left ventricular hypertrophy: results of a randomized trial comparing the angiotensin receptor antagonist, candesartan and the angiotensin-converting enzyme inhibitor, enalapril

F. Magrini, A. Zanchetti, M. Muiesan, 2009, Journal of hypertension.

Homing of peripherally injected bone marrow cells in rat after experimental myocardial injury.

F. Magrini, A. Giorgetti, P. Rebulla, 2003, Haematologica.

Different Effects of Antihypertensive Therapies Based on Losartan or Atenolol on Ultrasound and Biochemical Markers of Myocardial Fibrosis: Results of a Randomized Trial

F. Magrini, A. Zanchetti, M. Nicholls, 2004, Circulation.